11-Feb-2026 1:59 PM CST - Yahoo Finance BofA Remains Bullish on McKesson (MCK) Following Strong Third Quarter Performance McKesson Corporation (NYSE:MCK) is one of the best performing S&P 500 stocks in the last five years. On February 5, 2026, BofA reaffirmed its 'Buy' rating on McKesson Corporation (NYSE:MCK) and increased its price target from $950 to $970.
6-Feb-2026 9:21 AM CST - Forbes How McKesson Stock Surged 17% In A Day McKesson (MCK), a prominent pharmaceutical wholesaler, experienced a stock increase of 17% during a high-volume trading session.
5-Feb-2026 10:54 AM CST - Yahoo Finance McKesson Earnings Beat Highlights Oncology Growth And Medical Surgical Separation Plans McKesson (NYSE:MCK) reported a strong fiscal third quarter with double-digit growth in revenue and adjusted EPS. The company expanded its oncology, biopharma services, and North American pharmaceutical distribution operations during the quarter.
5-Feb-2026 10:33 AM CST - Yahoo Finance McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True? According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic.
4-Feb-2026 7:11 PM CST - Yahoo Finance McKesson (MCK) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
4-Feb-2026 6:12 PM CST - Yahoo Finance McKesson (MCK) Q3 Earnings and Revenues Top Estimates McKesson (MCK) delivered earnings and revenue surprises of +0.35% and +0.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
4-Feb-2026 5:01 PM CST - Reuters McKesson boosts 2026 profit forecast amid specialty drug growth McKesson Corporation raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.
Latest MCK Trades by Congress Members
19-DEC-2025 - Gilbert Cisneros, CA (District 31) sold between $1,001 and $15,000.
11-Feb-2026 1:59 PM CST - Yahoo Finance BofA Remains Bullish on McKesson (MCK) Following Strong Third Quarter Performance McKesson Corporation (NYSE:MCK) is one of the best performing S&P 500 stocks in the last five years. On February 5, 2026, BofA reaffirmed its 'Buy' rating on McKesson Corporation (NYSE:MCK) and increased its price target from $950 to $970.
6-Feb-2026 9:21 AM CST - Forbes How McKesson Stock Surged 17% In A Day McKesson (MCK), a prominent pharmaceutical wholesaler, experienced a stock increase of 17% during a high-volume trading session.
5-Feb-2026 10:54 AM CST - Yahoo Finance McKesson Earnings Beat Highlights Oncology Growth And Medical Surgical Separation Plans McKesson (NYSE:MCK) reported a strong fiscal third quarter with double-digit growth in revenue and adjusted EPS. The company expanded its oncology, biopharma services, and North American pharmaceutical distribution operations during the quarter.
5-Feb-2026 10:33 AM CST - Yahoo Finance McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True? According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic.
4-Feb-2026 7:11 PM CST - Yahoo Finance McKesson (MCK) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
4-Feb-2026 6:12 PM CST - Yahoo Finance McKesson (MCK) Q3 Earnings and Revenues Top Estimates McKesson (MCK) delivered earnings and revenue surprises of +0.35% and +0.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
4-Feb-2026 5:01 PM CST - Reuters McKesson boosts 2026 profit forecast amid specialty drug growth McKesson Corporation raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.
